Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121)

NCT01076088 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

744

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin 50 mg
DRUG: Metformin 500 mg
DRUG: Sitagliptin 100 mg
DRUG: Placebo
DRUG: Metformin 850 mg

Sponsor

Merck Sharp & Dohme LLC